The Pokeno facility is world-class, with a proven track record of producing high-quality infant milk formula The a2 Milk Company confirmed that it has completed the acquisition of an integrated…

The Pokeno facility is world-class, with a proven track record of producing high-quality infant milk formula

The a2 Milk Company confirmed that it has completed the acquisition of an integrated nutritional manufacturing facility with two China-label infant milk formula product registrations, located in Pokeno, New Zealand. 

Managing Director and Chief Executive Officer David Bortolussi said, “The completion of the acquisition is a significant step forward in the execution of our supply chain transformation strategy. With full ownership, we gain strategic control over two China label registrations, which we plan to relaunch under The a2 Milk Company brand within 12-18 months, with access to a potential third registration slot over time (all subject to China regulatory approvals).  The Pokeno facility is world-class with a proven track record of producing high-quality infant milk formula, including our English label products, a2 Gentle Gold™ and a2 Genesis™.”

Chair Pip Greenwood said, “This acquisition is a pivotal step in delivering our strategy. It also provides clarity on future capital requirements. It brings us closer to returning value to shareholders through an intended $300 million special dividend, subject to China label regulatory approvals in connection with the Pokeno acquisition and completion of the MVM divestment.” For further details on the acquisition, please refer to the Company’s FY25 Annual results and Supply Chain Transformation update investor presentation dated 18 August 2025.